Global Pet Meds and Supplements Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Pet Meds and Supplements Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Pet Meds and Supplements report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pet Meds and Supplements market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Dogs and Cats are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pet Meds and Supplements industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Pet Meds and Supplements key manufacturers include Boehringer Ingelheim, Ceva Sante Animale, Bimeda Animal Health, Dechra Pharmaceuticals, Zoetis, Merck, Elanco, Bayer and Boehringer, etc. Boehringer Ingelheim, Ceva Sante Animale, Bimeda Animal Health are top 3 players and held % sales share in total in 2022.
Pet Meds and Supplements can be divided into External Use and Oral Use, etc. External Use is the mainstream product in the market, accounting for % sales share globally in 2022.
Pet Meds and Supplements is widely used in various fields, such as Dogs, Cats, Rabbit and Bird, etc. Dogs provides greatest supports to the Pet Meds and Supplements industry development. In 2022, global % sales of Pet Meds and Supplements went into Dogs filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pet Meds and Supplements market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Boehringer Ingelheim
Ceva Sante Animale
Bimeda Animal Health
Dechra Pharmaceuticals
Zoetis
Merck
Elanco
Bayer
Boehringer
Novartis
Virbac
Ceva
Vetoquinol
Nexvet
Aratana Therapeutics
Kindred Biosciences
Ambrx
Entest Biomedical
Taconic Biosciences
Dechra Veterinary Products
Ouro Fino Saude
Norbrook
Frontline
Zesty Paws
Segment by Type
External Use
Oral Use
Dogs
Cats
Rabbit
Bird
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Pet Meds and Supplements market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pet Meds and Supplements, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pet Meds and Supplements industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Pet Meds and Supplements in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pet Meds and Supplements introduction, etc. Pet Meds and Supplements Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Pet Meds and Supplements market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
North America, Europe and Asia Pacific are the key regions for Pet Meds and Supplements industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Pet Meds and Supplements key manufacturers include Boehringer Ingelheim, Ceva Sante Animale, Bimeda Animal Health, Dechra Pharmaceuticals, Zoetis, Merck, Elanco, Bayer and Boehringer, etc. Boehringer Ingelheim, Ceva Sante Animale, Bimeda Animal Health are top 3 players and held % sales share in total in 2022.
Pet Meds and Supplements can be divided into External Use and Oral Use, etc. External Use is the mainstream product in the market, accounting for % sales share globally in 2022.
Pet Meds and Supplements is widely used in various fields, such as Dogs, Cats, Rabbit and Bird, etc. Dogs provides greatest supports to the Pet Meds and Supplements industry development. In 2022, global % sales of Pet Meds and Supplements went into Dogs filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pet Meds and Supplements market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Boehringer Ingelheim
Ceva Sante Animale
Bimeda Animal Health
Dechra Pharmaceuticals
Zoetis
Merck
Elanco
Bayer
Boehringer
Novartis
Virbac
Ceva
Vetoquinol
Nexvet
Aratana Therapeutics
Kindred Biosciences
Ambrx
Entest Biomedical
Taconic Biosciences
Dechra Veterinary Products
Ouro Fino Saude
Norbrook
Frontline
Zesty Paws
Segment by Type
External Use
Oral Use
Segment by Application
Dogs
Cats
Rabbit
Bird
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Pet Meds and Supplements market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pet Meds and Supplements, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pet Meds and Supplements industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Pet Meds and Supplements in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pet Meds and Supplements introduction, etc. Pet Meds and Supplements Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Pet Meds and Supplements market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.